Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia.
Canali A, Vergnolle I, Bertoli S, Largeaud L, Nicolau ML, Rieu JB, Tavitian S, Huguet F, Picard M, Bories P, Vial JP, Lechevalier N, Béné MC, Luquet I, Mansat-De Mas V, Delabesse E, Récher C, Vergez F.
Canali A, et al.
Clin Cancer Res. 2023 Jan 4;29(1):134-142. doi: 10.1158/1078-0432.CCR-22-2237.
Clin Cancer Res. 2023.
PMID: 36318706